 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- bupivacaine microsphere (ND-340) / Nang Kuang Pharma
Trial completion date, Trial primary completion date: A Phase I Dose-escalation Study of a Single Administration of Extended-Release Injectable Suspension (ND-340) (clinicaltrials.gov) - Nov 9, 2023
P1, N=36, Suspended, Sponsor: Nang Kuang Pharmaceutical Co., Ltd.
Trial completion date: Mar 2024 --> Jun 2026 | Trial primary completion date: Dec 2023 --> Dec 2025
- | bupivacaine microsphere (ND-340) / Nang Kuang Pharma
Trial completion date, Trial primary completion date: A Phase I Study to Evaluate the Safety and PK of ND-340 in Healthy Volunteers (clinicaltrials.gov) - Nov 9, 2023
P1, N=40, Recruiting, Sponsor: Nang Kuang Pharmaceutical Co., Ltd.
Trial completion date: Mar 2024 --> Jun 2026 | Trial primary completion date: Dec 2023 --> Dec 2025 Trial completion date: Dec 2023 --> Dec 2024 | Trial primary completion date: Jun 2023 --> Dec 2024
- || bupivacaine microsphere (ND-340) / Nang Kuang Pharma
New P1 trial: A Phase I Study to Evaluate the Safety and PK of ND-340 in Healthy Volunteers (clinicaltrials.gov) - Oct 20, 2022
P1, N=40, Recruiting, Sponsor: Nang Kuang Pharmaceutical Co., Ltd.
- ||| bupivacaine microsphere (ND-340) / Nang Kuang Pharma
Trial completion date, Trial suspension, Trial primary completion date: A Phase I Dose-escalation Study of a Single Administration of Extended-Release Injectable Suspension (ND-340) (clinicaltrials.gov) - Jul 7, 2022
P1, N=36, Suspended, Sponsor: Nang Kuang Pharmaceutical Co., Ltd.
Trial completion date: Dec 2023 --> Dec 2024 | Trial primary completion date: Jun 2023 --> Dec 2024 Trial completion date: Mar 2022 --> Mar 2024 | Recruiting --> Suspended | Trial primary completion date: Dec 2021 --> Dec 2023
- || bupivacaine microsphere (ND-340) / Nang Kuang Pharma
New P1 trial: A Phase I Dose-escalation Study of a Single Administration of Extended-Release Injectable Suspension (ND-340) (clinicaltrials.gov) - Aug 16, 2020
P1, N=36, Recruiting, Sponsor: Nang Kuang Pharmaceutical Co., Ltd.